{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:15:30Z","timestamp":1783649730393,"version":"3.55.0"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>High-Grade Gliomas (HGG) are the most frequent brain tumor in adults. The gold standard of clinical care recommends beginning chemoradiation within 6 weeks of surgery. Disparities in access to healthcare in Argentina are notorious, often leading to treatment delays. We conducted this retrospective study to evaluate if time to chemoradiation after surgery is correlated with progression-free survival (PFS). Our study included clinical cases with a histological diagnosis of Glioblastoma (GBM), Anaplastic Astrocytoma (AA) or High-Grade Glioma (HGG) in patients over 18 years of age from 2014 to 2020. We collected data on clinical presentation, type of resection, time to surgery, time to chemoradiation, location within the Buenos Aires Metropolitan Area (BAMA) and type of health insurance. We found 63 patients that fit our inclusion criteria, including 26 (41.3%) females and 37 (58.7%) males. Their median age was 54 years old (19\u201386). Maximal safe resection was achieved in 49.2% (n = 31) of the patients, incomplete resection in 34.9% (n = 22) and the other 15.9% (n = 10) received a biopsy, but no resection. The type of health care insurance was almost evenly divided, with 55.6% (n = 35) of the patients having public vs. 44.4% (n = 28) having private health insurance. Median time to chemoradiation after surgery was 8 (CI 6.68\u20139.9) weeks for the global population. When we ordered the patients PFS by time to chemoradiation we found that there was a statistically significant effect of time to chemoradiation on patient PFS. Patients had a PFS of 10 months (p = 0.014) (CI 6.89\u201313.10) when they received chemoradiation &lt;5 weeks vs a PFS of 7 months (CI 4.93\u20139.06) when they received chemoradiation between 5 to 8 weeks and a PFS of 4 months (CI 3.76\u20134.26 HR 2.18 p = 0.006) when they received chemoradiation &gt;8 weeks after surgery. Also, our univariate and multivariate analysis found that temporal lobe location (p = 0.03), GMB histology (p = 0.02) and biopsy as surgical intervention (p = 0.02) all had a statistically significant effect on patient PFS. Thus, time to chemoradiation is an important factor in patient PFS. Our data show that although an increase in HGG severity contributes to a decrease in patient PFS, there is also a large effect of time to chemoradiation. Our results suggest that we can improve patient PFS by making access to healthcare in Buenos Aires more equitable by reducing the average time to chemoradiation following tumor resection.<\/jats:p>","DOI":"10.1371\/journal.pone.0249486","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T17:27:07Z","timestamp":1617384427000},"page":"e0249486","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of time to chemoradiation on high-grade gliomas from the Buenos Aires Metropolitan Area"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4962-8611","authenticated-orcid":true,"given":"Diego M.","family":"Prost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn A.","family":"Merenzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 I.","family":"G\u00f3mez-Escalante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Primavera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Vargas Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5312-6406","authenticated-orcid":true,"given":"Andr\u00e9s S.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo M.","family":"Marenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda M.","family":"Califano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Moughty Cueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Zaloff Dakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Colonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mazz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto S.","family":"Zaninovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar R.","family":"De Crist\u00f3faro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"issue":"January","key":"pone.0249486.ref001","first-page":"1","volume":"19","author":"QT Ostrom","year":"2018","journal-title":"Neuro-Oncology CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United"},{"key":"pone.0249486.ref002","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma","author":"R., Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"Xx","key":"pone.0249486.ref003","first-page":"1","article-title":"versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813","author":"S Chang","year":"2016","journal-title":"Neuro Oncol"},{"issue":"1","key":"pone.0249486.ref004","first-page":"4","volume":"15","author":"M Weller","year":"2013","journal-title":"Standards of care for treatment of recurrent"},{"issue":"10","key":"pone.0249486.ref005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1200\/JOP.2017.025536","article-title":"Treatment of Glioblastoma","volume":"13","author":"JY Nam","year":"2018","journal-title":"J Oncol Pr"},{"issue":"3","key":"pone.0249486.ref006","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1200\/JCO.2016.70.7562","article-title":"Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline","volume":"20","author":"EP Sulman","year":"2016","journal-title":"J Clin Oncol"},{"issue":"March","key":"pone.0249486.ref007","first-page":"1","article-title":"The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol","volume":"9","author":"KT Warren","year":"2019","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0249486.ref008","first-page":"177","volume":"36","author":"C Iriart","year":"2006","journal-title":"Report from Argentina ARGENTINA: NO LESSON LEARNED"},{"key":"pone.0249486.ref009","author":"PLA Reproducci"},{"issue":"3","key":"pone.0249486.ref010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/23288604.2018.1477537","article-title":"A Blueprint for Reform Making Universal Health Care Effective in Argentina: A Blueprint for Reform","volume":"4","author":"A Rubinstein","year":"2018","journal-title":"Heal Syst Reform"},{"issue":"8","key":"pone.0249486.ref011","first-page":"1417","article-title":"Assessment of accessibility to the diagnosis and treatment of brain tumors in Argentina: Preliminary results","volume":"13","author":"AT Rabad\u00e1n","year":"2017","journal-title":"Surg Neurol Int"},{"key":"pone.0249486.ref012","doi-asserted-by":"crossref","unstructured":"Wen PY, Chang SM, Bent MJ Van Den, Vogelbaum MA, Macdonald DR, Lee EQ. Response Assessment in Neuro-Oncology Clinical Trials. 2017;","DOI":"10.1200\/JCO.2017.72.7511"},{"key":"pone.0249486.ref013","unstructured":"Argentina PL de la R. Derechos del Paciente en su Relaci\u00f3n con los Profesionales e Instituciones de la Salud. Ley 26.529. Sanci\u00f3n: 21\/10\/2009; Promulgaci\u00f3n de Hecho: 19\/11\/2009; Bolet\u00edn Oficial 20\/11\/2009. 2009."},{"key":"pone.0249486.ref014","first-page":"2197","author":"CV Machado","journal-title":"Health Policies in Argentina, Brazil and Mexico: different paths, many challenges"},{"issue":"2","key":"pone.0249486.ref015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1200\/JGO.2016.004911","article-title":"Surgery for CNS Tumors in the Brazilian National Health Care System","volume":"3","author":"Luciola Pontes","year":"2020","journal-title":"J Glob Oncol"},{"key":"pone.0249486.ref016","article-title":"Maximizing safe resection of low- and high-grade glioma","author":"SLHMS Berger","year":"2016","journal-title":"J Neurooncol"},{"key":"pone.0249486.ref017","article-title":"cIMPACT \u2011 NOW update 3: recommended diagnostic criteria for \u201cDiffuse astrocytic glioma, IDH \u2011 wildtype, with molecular features of glioblastoma, WHO grade IV.\u201d","author":"DJ Brat","year":"2018","journal-title":"Acta Neuropathol"},{"key":"pone.0249486.ref018","article-title":"cIMPACT \u2011 NOW update 5: recommended grading criteria and terminologies for IDH \u2011 mutant astrocytomas","author":"DJ Brat","year":"2020","journal-title":"Acta Neuropathol"},{"key":"pone.0249486.ref019","first-page":"174","article-title":"On High-Risk, Low-Grade Glioma","year":"2019","journal-title":"What Distinguishes High From Low?"},{"issue":"3","key":"pone.0249486.ref020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11060-007-9426-z","article-title":"Delay in radiotherapy shortens survival in patients with high grade glioma","volume":"85","author":"C Irwin","year":"2007","journal-title":"J Neurooncol"},{"issue":"103","key":"pone.0249486.ref021","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.wneu.2017.04.041","article-title":"Extent of Resection in Glioma-A Review of the Cutting Edge","author":"RS D\u2019Amico","year":"2017","journal-title":"World Neurosurg"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0249486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T17:27:28Z","timestamp":1617384448000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0249486"}},"subtitle":[],"editor":[{"given":"Michael C.","family":"Burger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0249486","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,2]]}}}